Bayer Partners with Stanford Startup Phylo to Speed Up Drug Discovery

Bayer has partnered with Stanford AI startup Phylo to use its Biomni Lab product, built on the open-source Biomni agent, to aid drug discovery. Phylo recently raised $13.5 million in seed funding.

2026-10-25 ~ 2026-10-25 · 2 related posts

• Bayer Taps Stanford AI Startup Phylo (Biomni Lab) for Drug Discovery After $13.5M Seed — RichardsonDx · 2026-10-25

1 near-duplicate retellings: RichardsonDx